Pharmaceutical Companies Sign Declaration to Act Against Antibiotics

Contributed by Siddarth D & Dr. Tamhankar

In a first of its kind step, drug makers have pledged  joined hands with governments and other bodies working on addressing the problem of antibiotic resistance. Declaration on Combating Antimicrobial Resistance was signed by 85 phrama, bio-tech and drug companies including GlaxoSmithKline, Johnson & Johnson, Novartis and Pfizer as well as Cipla from India, to adhere to a common set of protocols keeping in mind antibiotic conservation.

The declaration was launched as part of the World Economic Forum in Davos, Switzerland, and outlines several key measures the government and industry must take to increase antibiotic effectiveness worldwide. This was done in collaboration the Review on Antimicrobial Resistance, a group commissioned by the UK Prime Minister for the purpose of raising awareness for the economic issues surrounding antimicrobial resistance (AMR).

This 21st January declaration, has broadened the scope of involving all the stakeholders in the process of tackling antibiotic resistance. Drug companies have been criticised for not doing enough to control the market forces that impeded unregulated production and sale of antibiotics. Rather than working in silos, it is only when policy makers, field workers, researchers and drug companies are on the same page, that effective steps can be taken to rationalize the use of antibiotics.  It is hoped that more drug makers sign the declaration and are part of the solution rather than the problem to antibiotic resistance.